PETMED EXPRESS, INC.

(PETS)
  Report
Real-time Estimate Cboe BZX  -  05/23 03:06:33 pm EDT
20.41 USD   +2.28%
05/19PETMED EXPRESS, INC. : Ex-dividend day for
FA
05/10PETMED EXPRESS INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/10PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PetMed Express, Inc. Provides Sales Guidance for the Year 2022

01/24/2022 | 04:30pm EDT

PetMed Express, Inc. provided sales guidance for the year 2022. The company expects to see stronger reorder sales in 2022 as its AutoShip revenue continues to grow.


© S&P Capital IQ 2022
All news about PETMED EXPRESS, INC.
05/19PETMED EXPRESS, INC. : Ex-dividend day for
FA
05/10PETMED EXPRESS INC : Results of Operations and Financial Condition, Regulation FD Disclosu..
AQ
05/10PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/10Morgan Stanley Adjusts PetMed Express' Price Target to $20 from $21, Keeps Underweight ..
MT
05/09PETMED : Fiscal Q4 Earnings Snapshot
AQ
05/09TRANSCRIPT : PetMed Express, Inc., Q4 2022 Earnings Call, May 09, 2022
CI
05/09PetMed Express Reports Lower Fiscal Q4 Earnings, Sales
MT
05/09Earnings Flash (PETS) PETMED EXPRESS Posts Q4 EPS $0.30, vs. Street Est of $0.25
MT
05/09Earnings Flash (PETS) PETMED EXPRESS Posts Q4 Revenue $66M
MT
05/09PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declare..
GL
More news
Analyst Recommendations on PETMED EXPRESS, INC.
More recommendations
Financials (USD)
Sales 2022 277 M - -
Net income 2022 20,2 M - -
Net cash 2022 113 M - -
P/E ratio 2022 20,2x
Yield 2022 6,07%
Capitalization 404 M 404 M -
EV / Sales 2022 1,05x
EV / Sales 2023 1,02x
Nbr of Employees 219
Free-Float 93,2%
Chart PETMED EXPRESS, INC.
Duration : Period :
PetMed Express, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PETMED EXPRESS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 19,95 $
Average target price 24,00 $
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Matthew N. Hulett President, Chief Executive Officer & Director
Bruce S. Rosenbloom Chief Financial Officer & Treasurer
Gian Mark Fulgoni Chairman
Mark Moseley Chief Technology & Information Officer
Ronald J. Korn Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PETMED EXPRESS, INC.-21.02%404
RAIA DROGASIL S.A.-24.69%6 194
AIN HOLDINGS INC.-0.17%1 571
QOL HOLDINGS CO., LTD.-14.14%346
HLS THERAPEUTICS INC.-10.73%339
RITE AID CORPORATION-61.74%313